Vitamin E: The Antioxidant You Should Be Testing

What vitamin E actually does

Vitamin E is not a single molecule but a family of eight fat-soluble compounds: four tocopherols and four tocotrienols. Of these, alpha-tocopherol is the most biologically active form in humans and the one measured in clinical testing. Its primary function is as a chain-breaking antioxidant — it intercepts free radicals that would otherwise damage the polyunsaturated fatty acids in cell membranes, lipoproteins, and other lipid structures.

This protective role is particularly important in tissues with high oxidative exposure: the lungs, the retina, red blood cells, and the nervous system. Vitamin E also modulates immune function, inhibits platelet aggregation, and influences gene expression through its effects on cell signalling pathways.

Who is at risk of deficiency?

Because vitamin E is fat-soluble and widely distributed in dietary fats, overt deficiency is uncommon in the general population. However, it can be significant in specific groups. Individuals with fat malabsorption disorders — including coeliac disease, Crohn's disease, cystic fibrosis, and chronic pancreatitis — are at elevated risk because they cannot efficiently absorb dietary vitamin E from the gut.

Premature infants are another high-risk group, as vitamin E stores are largely established during the third trimester of pregnancy. People with abetalipoproteinaemia or other genetic conditions affecting lipid transport can develop severe vitamin E deficiency leading to progressive neurological damage if left untreated. Additionally, individuals on very low-fat diets or those taking medications that interfere with fat absorption (such as orlistat) may develop suboptimal levels over time.

What does the test measure?

The standard test measures alpha-tocopherol concentration in serum or plasma. At Masdiag, we quantify alpha-tocopherol using LC-MS/MS from a dried blood spot — the same gold-standard analytical platform used for our other fat-soluble vitamin assays. Normal alpha-tocopherol levels typically range from 12 to 46 µmol/L, though optimal ranges may vary depending on lipid levels and clinical context.

An important consideration is that because vitamin E circulates bound to lipoproteins, serum levels can be influenced by total lipid concentrations. In individuals with high cholesterol or triglycerides, alpha-tocopherol may appear artificially elevated. Some clinicians therefore recommend interpreting vitamin E results in the context of lipid panels, using a ratio of alpha-tocopherol to total lipids for a more accurate assessment of tissue status.

Clinical consequences of deficiency

Prolonged vitamin E deficiency can lead to peripheral neuropathy — numbness, tingling, and loss of sensation in the hands and feet — as well as ataxia (loss of coordination), skeletal myopathy, and retinal degeneration. In the immune system, low vitamin E impairs T-cell function and increases susceptibility to infections, particularly in older adults.

These consequences develop gradually, and early deficiency is often asymptomatic. This makes proactive testing especially valuable for at-risk individuals, where catching declining levels early allows for targeted supplementation before irreversible neurological damage occurs.

The supplementation landscape

Vitamin E supplementation has a complex history. While adequate vitamin E is clearly essential, high-dose supplementation trials have produced mixed and sometimes concerning results. Some large-scale studies found that doses above 400 IU per day were associated with a modest increase in all-cause mortality, though these findings remain debated. Testing provides an objective basis for supplementation decisions — confirming whether an individual actually needs supplementation and monitoring whether target levels are being achieved, rather than relying on population-level dosing guidelines.